[Retinopathy of prematurity - therapy. Part 2].

Abstract

Retinopathy of prematurity (ROP) is a disease that affects immature vasculature in the eyes of premature babies that potentially leads to blindness. Authors describe revised indications for the treatment of ROP, standard treatment - peripheral retinal ablation by laser photocoagulation and the cryotherapy using off label treatment-intravitreal anti-VEGF injection. Key words: retinopathy of prematurity, indications, laser photocoagulation, cryotherapy, intravitreal anti-VEGF therapy.

• Authors: Z Prepiaková, D Tomčíková, B Kostolná, A Gerinec
• Journal: Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti (Cesk Slov Oftalmol) Vol. 70 Issue 2 Pg. 50-4 (Apr 2014) ISSN: 1211-9059 [Print] Czech Republic
• Vernacular Title: Retinopatia prematúrnych detí - terapia II. časť
• PMID: 25030312 (Publication Type: Journal Article, Review)

Chemical References

• Angiogenesis Inhibitors
• Antibodies, Monoclonal, Humanized
• Vascular Endothelial Growth Factor A
• Bevacizumab

Topics

• Angiogenesis Inhibitors (administration & dosage)
• Antibodies, Monoclonal, Humanized (administration & dosage)
• Bevacizumab
• Cryotherapy (methods)
• Humans
• Infant, Newborn
• Intravitreal Injections
• Laser Coagulation (methods)
• Retinopathy of Prematurity (therapy)
• Vascular Endothelial Growth Factor A (antagonists & inhibitors)